By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eddingpharm (Cayman) Inc. 



Wanchai  Hong Kong    China
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Immutep S.A. And Eddingpharm (Cayman) Inc. Start Production Of Immufact® IMP321 At WuXi AppTec, Inc. In China 4/8/2014 1:36:01 PM
Week in Review: Eddingpharm (Cayman) Inc. Buys ACT Biotech Assets For $95 Million 1/13/2014 8:50:25 AM
Eddingpharm (Cayman) Inc. Acquired Global Rights To Oncology Assets, Including Telatinib, From ACT Biotech 1/8/2014 10:02:49 AM
Week in Review: Eddingpharm (Cayman) Inc. In-Licenses China Rights to Bone Drug for $2.7 Million Upfront 10/21/2013 8:47:07 AM
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. to Develop and Commercialise Its Anti-Rankl Nanobody in Greater China 10/18/2013 11:04:25 AM
Immutep S.A. and Eddingpharm (Cayman) Inc. Sign Agreement for Development of ImmuFact® IMP321 in China 10/7/2013 9:25:53 AM
Eddingpharm (Cayman) Inc. and Chiesi Farmaceutici SpA Form Asthma Drug JV 4/16/2013 9:08:36 AM
Eddingpharm (Cayman) Inc. to Distribute Breast Cancer Drug for GlaxoSmithKline (GSK) in China 4/9/2013 6:49:39 AM
//-->